Suchergebnisse - "Urticaria"

PubPharm (10.031)

1

Yellow urticaria following plasma transfusion

enthalten in: The Journal of dermatology | 2024

von Pan, X. | Dong, Z.

2

Does chronic urticaria affect quality of sleep and quality of life?

enthalten in: Journal of public health research | 2024

von Abdel-Meguid, A. | Awad, S. | Noaman, M. | +2

3

Intersecting pathways : evaluating inflammatory markers and metabolism in chronic spontaneous urticaria with a multi-marker approach

enthalten in: International journal of dermatology | 2024

von Metin, Z. | Akca, H. | Tur, K. | +1

4

A case of Schnitzler-like syndrome with basement membrane IgM deposition but without monoclonal gammopathy

enthalten in: JAAD case reports | 2024

von Ghali, H. | McClure, E. | Foster, E.

5

Non-Skin-Related Symptoms are Common in Chronic Spontaneous Urticaria and Linked to Active and Uncontrolled Disease : Results from CURE

enthalten in: The journal of allergy and clinical immunology. In practice | 2024

von Pyatilova, P. | Hackler, Y. | Aulenbacher, F. | +30

6

An Extension Study of Long-term Efficacy, Safety and Tolerability of Remibrutinib in Chronic Spontaneous Urticaria Patients Who Completed Preceding Studies With Remibrutinib : A Multicenter, Double-blind, Placebo-controlled, Randomized Withdrawal and Open-label Extension Study Followed by Long-term Open-label Treatment Cycles to Assess the Efficacy, Safety and Tolerability of Remibrutinib (LOU064) in Adult Chronic Spontaneous Urticaria Patients Who Completed the Preceding Remibrutinib Phase 3 Studies

enthalten in: ClinicalTrials.gov | 2024

7

A Study to Investigate Efficacy, Safety, and Tolerability of Remibrutinib Compared With Placebo in Adults With CINDU Inadequately Controlled by H1-antihistamines : A 52-week Multi-center, Randomized, Double-blind, Placebo Controlled, Basket Study With an Open-label Extension to Investigate the Efficacy, Safety, and Tolerability of Remibrutinib (LOU064) in Chronic Inducible Urticaria (CINDU) in Adults Inadequately Controlled by H1-antihistamines

enthalten in: ClinicalTrials.gov | 2024

8

A Phase 3b Study to Assess the Efficacy, Safety, and Tolerability of Remibrutinib in Comparison to Placebo and With Omalizumab as Active Control in CSU Adult Patients. : A Global, Multicenter, Randomized, Double-blind, Double-dummy, Parallel-group, Phase 3b Study to Assess the Efficacy, Safety, and Tolerability of Remibrutinib 25 mg b.i.d. in Comparison to Placebo With Omalizumab 300 mg Every 4 Weeks as Active Control Over 52 Weeks in Adult Patients With Chronic Spontaneous Urticaria Inadequately Controlled by Second-generation H1-antihistamines

enthalten in: ClinicalTrials.gov | 2024

9

An update on the use of antihistamines in managing chronic urticaria

enthalten in: Expert opinion on pharmacotherapy | 2024

von Xiang, Y. | Fok, J. | Podder, I. | +4

10

Mast cell signaling and its role in urticaria

enthalten in: Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology | 2024

von Puxeddu, I. | Pistone, F. | Pisani, F. | +1

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[1004]